Deep Brain Stimulation in Parkinson’s Disease: Assessing Efficacy

References

• Tysnes O-B, Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm. 2017;124(8):901–905. doi:10.1007/s00702-017-1686-y
   PubMed Web of Science ®Google Scholar
• Ball N, Teo W-P, Chandra S, Chapman J. Parkinson’s Disease and the Environment. Front Neurol. 2019;10:10. doi:10.3389/fneur.2019.00218
   Google Scholar
• Balestrino R, Schapira AHV. Parkinson disease. Eur J Neurol. 2020;27(1):27–42. doi:10.1111/ene.14108
   PubMed Web of Science ®Google Scholar
• Bratsos S, Karponis D, Saleh SN. Efficacy and Safety of Deep Brain Stimulation in the Treatment of Parkinson’s Disease: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Cureus. 2018;10:10. doi:10.7759/cureus.3474
   Web of Science ®Google Scholar
• Pradahan M, Srivastava R. Etiology. Epidemiology, Diagnosis and Current Therapeutic Protocols for Parkinson’s Disease (PD): an Overview. Int J Contemporary Med Surg Radiol. 2020;5. doi:10.21276/ijcmsr.2020.5.1.41
   Google Scholar
• Parastarfeizabadi M, Kouzani AZ. Advances in closed-loop deep brain stimulation devices. J Neuroeng Rehabil. 2017;14(1):79. doi:10.1186/s12984-017-0295-1
   PubMedGoogle Scholar
• deSouza R-M, Moro E, Lang AE, Schapira AHV. Timing of deep brain stimulation in Parkinson disease: a need for reappraisal? Ann Neurol. 2013;73(5):565–575. doi:10.1002/ana.23890
   PubMed Web of Science ®Google Scholar
• Thomsen BLC, Jensen SR, Clausen A, Karlsborg M, Jespersen B. Deep Brain Stimulation in Parkinson’s Disease: still Effective After More Than 8 Years. Movement Dis Clin Pract. 2020;7(7):788–796. doi:10.1002/mdc3.13040
   Web of Science ®Google Scholar
• Cagnan H, Denison T, McIntyre C, Brown P. Emerging technologies for improved deep brain stimulation. Nat Biotechnol. 2019;37(9):1024–1033. doi:10.1038/s41587-019-0244-6
   PubMed Web of Science ®Google Scholar
• Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain. 2005;128(10):2240–2249. doi:10.1093/brain/awh571
   PubMed Web of Science ®Google Scholar
• Anderson D, Beecher G, Ba F. Deep Brain Stimulation in Parkinson’s Disease: new and Emerging Targets for Refractory Motor and Nonmotor Symptoms. Parkinson’s Disease. 2017;2017. doi:10.1155/2017/5124328
   Web of Science ®Google Scholar
• Chao Y, Gang L, Na ZL, Ming WY, Zhong WS, Mian WS. Surgical Management of Parkinson’s Disease: update and Review. Interv Neuroradiol. 2007;13(4):359–368. doi:10.1177/159101990701300407
   PubMed Web of Science ®Google Scholar
• Hitti FL, Ramayya AG, McShane BJ, Yang AI, Vaughan KA, Baltuch GH. Long-term outcomes following deep brain stimulation for Parkinson’s disease. J Neurosurg. 2019;132(1):205–210. doi:10.3171/2018.8.JNS182081
   Web of Science ®Google Scholar
• Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord. 2002;17(5):867–876. doi:10.1002/mds.10248
   PubMed Web of Science ®Google Scholar
• Goetz CG, LeWitt PA, Weidenman M. Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program. Mov Disord. 2003;18(12):1455–1458. doi:10.1002/mds.10591
   Web of Science ®Google Scholar
• Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the unified Parkinson’s disease rating scale. Mov Disord. 1995;10(3):263–266. doi:10.1002/mds.870100305
   Web of Science ®Google Scholar
• Goetz CG, Stebbins GT. Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape. Mov Disord. 2004;19(12):1453–1456. doi:10.1002/mds.20220
   Web of Science ®Google Scholar
• Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the historical section of the Unified Parkinson’s Disease Rating Scale. Mov Disord. 1996;11(2):185–192. doi:10.1002/mds.870110212
   PubMed Web of Science ®Google Scholar
• Goetz CG, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord. 2007;22(1):41–47. doi:10.1002/mds.21198
   PubMed Web of Science ®Google Scholar
• Chou KL, Taylor JL, Patil PG. The MDS–UPDRS tracks motor and non–motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease. Parkinsonism Relat Disord. 2013;19:11. doi:10.1016/j.parkreldis.2013.06.010
   Web of Science ®Google Scholar
• Dong W, Qiu C, Jiang X, et al. Can the Executive Control Network be Used to Diagnose Parkinson’s Disease and as an Efficacy Indicator of Deep Brain Stimulation? Parkinson’s Disease. 2020;2020. doi:10.1155/2020/6348102
   Web of Science ®Google Scholar
• Dallapiazza RF, Vloo PD, Fomenko A, et al. Considerations for Patient and Target Selection in Deep Brain Stimulation Surgery for Parkinson’s Disease. Codon Publications; 2018. doi:10.15586/codonpublications.parkinsonsdisease.2018.ch8
   Google Scholar
• Pouratian N, Thakkar S, Kim W, Bronstein JM. Deep brain stimulation for the treatment of Parkinson’s disease: efficacy and safety. Degener Neurol Neuromuscul Dis. 2012;2:107–117. doi:10.2147/DNND.S25750
   Google Scholar
• Geraedts VJ, Kuijf ML, van Hilten JJ, Marinus J, Oosterloo M, Contarino MF. Selecting candidates for Deep Brain Stimulation in Parkinson’s disease: the role of patients’ expectations. Parkinsonism Relat Disord. 2019;66:207–211. doi:10.1016/j.parkreldis.2019.07.011
   Web of Science ®Google Scholar
• Mirza S, Yazdani U, Dewey III R, et al. Comparison of Globus Pallidus Interna and Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease: an Institutional Experience and Review. Parkinson’s Disease. 2017;2017. doi:10.1155/2017/3410820
   Web of Science ®Google Scholar
• Mao Z, Ling Z, Pan L, et al. Comparison of Efficacy of Deep Brain Stimulation of Different Targets in Parkinson’s Disease: a Network Meta-Analysis. Front Aging Neurosci. 2019:11. doi:10.3389/fnagi.2019.00023
   Web of Science ®Google Scholar
• Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease. Neurology. 2012;79(1):55–65. doi:10.1212/WNL.0b013e31825dcdc1
   PubMed Web of Science ®Google Scholar
• Odekerken VJJ, Boel JA, Schmand BA, et al. GPi vs STN deep brain stimulation for Parkinson disease: three-year follow-up. Neurology. 2016;86(8):755–761. doi:10.1212/WNL.0000000000002401
   PubMed Web of Science ®Google Scholar
• Rughani A, Schwalb JM, Sidiropoulos C, et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson’s Disease: executive Summary. Neurosurgery. 2018;82(6):753–756. doi:10.1093/neuros/nyy037
   PubMed Web of Science ®Google Scholar
• Cernera S, Eisinger RS, Wong JK, et al. Long-term Parkinson’s disease quality of life after staged DBS: STN vs GPi and first vs second lead. NPJ Parkinsons Dis. 2020;6:6. doi:10.1038/s41531-020-0115-3
   Web of Science ®Google Scholar
• Rabie A, Verhagen Metman L, Fakhry M, et al. Improvement of Advanced Parkinson’s Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: a Single Institution Experience. Brain Sci. 2016;6:4. doi:10.3390/brainsci6040058
   Web of Science ®Google Scholar
• Rodriguez-Oroz MC, Zamarbide I, Guridi J, Palmero MR, Obeso JA. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry. 2004;75(10):1382–1385. doi:10.1136/jnnp.2003.031294
   PubMed Web of Science ®Google Scholar
• Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s disease. Mov Disord. 2010;25(5):578–586. doi:10.1002/mds.22735
   PubMed Web of Science ®Google Scholar
• St George RJ, Carlson-Kuhta P, King LA, Burchiel KJ, Horak FB. Compensatory stepping in Parkinson’s disease is still a problem after deep brain stimulation randomized to STN or GPi. J Neurophysiol. 2015;114(3):1417–1423. doi:10.1152/jn.01052.2014
   Web of Science ®Google Scholar
• Munhoz RP, Cerasa A, Okun MS. Surgical treatment of dyskinesia in Parkinson’s disease. Front Neurol. 2014;5:65. doi:10.3389/fneur.2014.00065
   Web of Science ®Google Scholar
• Tagliati M. Turning tables: should GPi become the preferred DBS target for Parkinson disease? Neurology. 2012;79(1):19–20. doi:10.1212/WNL.0b013e31825dce96
   Web of Science ®Google Scholar
• Follett KA, Weaver FM, Stern M, et al. Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson’s Disease. N Eng J Med. 2010;362(22):2077–2091. doi:10.1056/NEJMoa0907083
   PubMed Web of Science ®Google Scholar
• Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol. 2009;65(5):586–595. doi:10.1002/ana.21596
   PubMed Web of Science ®Google Scholar
• Odekerken VJJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol. 2013;12(1):37–44. doi:10.1016/S1474-4422(12)70264-8
   PubMed Web of Science ®Google Scholar
• Zahodne LB, Okun MS, Foote KD, et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol. 2009;256(8):1321–1329. doi:10.1007/s00415-009-5121-7
   Web of Science ®Google Scholar
• Combs HL, Folley BS, Berry DTR, et al. Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson’s Disease: a Meta-Analysis. Neuropsychol Rev. 2015;25(4):439–454. doi:10.1007/s11065-015-9302-0
   PubMed Web of Science ®Google Scholar
• Skodda S. Effect of Deep Brain Stimulation on Speech Performance in Parkinson’s Disease. Parkinson’s Disease. 2014. doi:10.1155/2012/850596
   Google Scholar
• Buhmann C, Huckhagel T, Engel K, et al. Adverse events in deep brain stimulation: a retrospective long-term analysis of neurological, psychiatric and other occurrences. PLoS One. 2017;12(7):e0178984. doi:10.1371/journal.pone.0178984
   PubMed Web of Science ®Google Scholar
• Troche MS, Brandimore AE, Foote KD, Okun MS. Swallowing and deep brain stimulation in Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2013;19(9):783–788. doi:10.1016/j.parkreldis.2013.05.001
   PubMed Web of Science ®Google Scholar
• Troche MS, Brandimore AE, Foote KD, et al. Swallowing Outcomes Following Unilateral STN vs. GPi Surgery: a Retrospective Analysis. Dysphagia. 2014;29(4):425–431. doi:10.1007/s00455-014-9522-0
   PubMed Web of Science ®Google Scholar
• Blomstedt P, Stenmark Persson R, Hariz G-M, et al. Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson’s disease: a randomised blinded evaluation. J Neurol Neurosurg Psychiatry. 2018;89(7):710–716. doi:10.1136/jnnp-2017-317219
   Web of Science ®Google Scholar
• Mostofi A, Evans JM, Partington-Smith L, Yu K, Chen C, Silverdale MA. Outcomes from deep brain stimulation targeting subthalamic nucleus and caudal zona incerta for Parkinson’s disease. Parkinson’s Dis. 2019;5(1):1–7. doi:10.1038/s41531-019-0089-1
   Google Scholar
• Little S, Tripoliti E, Beudel M, et al. Adaptive deep brain stimulation for Parkinson’s disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting. J Neurol Neurosurg Psychiatry. 2016;87(12):1388–1389. doi:10.1136/jnnp-2016-313518
   PubMed Web of Science ®Google Scholar
• Little S, Brown P. Debugging Adaptive Deep Brain Stimulation for Parkinson’s Disease. Mov Disorders. 2020;35(4):555–561. doi:10.1002/mds.27996
   PubMed Web of Science ®Google Scholar
• Rosin B, Slovik M, Mitelman R, et al. Closed-Loop Deep Brain Stimulation Is Superior in Ameliorating Parkinsonism. Neuron. 2011;72(2):370–384. doi:10.1016/j.neuron.2011.08.023
   PubMed Web of Science ®Google Scholar
• Parastarfeizabadi M, Kouzani AZ. A Miniature Dual-Biomarker-Based Sensing and Conditioning Device for Closed-Loop DBS. IEEE J Translat Eng Health Med. 2019;7:1–8. doi:10.1109/JTEHM.2019.2937776
   Google Scholar
• Ghasemi P, Sahraee T, Mohammadi A. Closed- and Open-loop Deep Brain Stimulation: methods, Challenges, Current and Future Aspects. J Biomed Phys Eng. 2018;8(2):209–216. doi:10.31661/jbpe.v8i2.898
   Google Scholar
• Ghahremani A, Aron AR, Udupa K, et al. Event-related deep brain stimulation of the subthalamic nucleus affects conflict processing. Ann Neurol. 2018;84(4):515–526. doi:10.1002/ana.25312
   Web of Science ®Google Scholar
• Patel SR, Herrington TM, Sheth SA, et al. Intermittent subthalamic nucleus deep brain stimulation induces risk-aversive behavior in human subjects. Elife. 2018:7. doi:10.7554/eLife.36460
   Web of Science ®Google Scholar
• Fischer P, Chen CC, Chang Y-J, et al. Alternating Modulation of Subthalamic Nucleus Beta Oscillations during Stepping. J Neurosci. 2018;38(22):5111–5121. doi:10.1523/JNEUROSCI.3596-17.2018
   Web of Science ®Google Scholar
• Sharma VD, Sengupta S, Chitnis S, Amara AW. Deep Brain Stimulation and Sleep-Wake Disturbances in Parkinson Disease: a Review. Front Neurol. 2018;9:697. doi:10.3389/fneur.2018.00697
   Google Scholar
• Timmermann L, Wojtecki L, Gross J, et al. Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson’s disease. Mov Disord. 2004;19(11):1328–1333. doi:10.1002/mds.20198
   Web of Science ®Google Scholar
• Eusebio A, Chen CC, Lu CS, et al. Effects of low-frequency stimulation of the subthalamic nucleus on movement in Parkinson’s disease. Exp Neurol. 2008;209(1):125–130. doi:10.1016/j.expneurol.2007.09.007
   PubMed Web of Science ®Google Scholar
• Phibbs FT, Arbogast PG, Davis TL. 60 Hz frequency effect on gait in Parkinson’s disease with subthalamic nucleus deep brain stimulation. Neuromodulation. 2014;17(8):717–720. doi:10.1111/ner.12131
   Web of Science ®Google Scholar
• Steigerwald F, Müller L, Johannes S, Matthies C, Volkmann J. Directional deep brain stimulation of the subthalamic nucleus: a pilot study using a novel neurostimulation device. Mov Disord. 2016;31(8):1240–1243. doi:10.1002/mds.26669
   PubMed Web of Science ®Google Scholar
• Timmermann L, Jain R, Chen L, et al. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson’s disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study. Lancet Neurol. 2015;14(7):693–701. doi:10.1016/S1474-4422(15)00087-3
   PubMed Web of Science ®Google Scholar
• Ho AL, Ali R, Connolly ID, et al. Awake versus asleep deep brain stimulation for Parkinson’s disease: a critical comparison and meta-analysis. J Neurol Neurosurg Psychiatry. 2018;89(7):687–691. doi:10.1136/jnnp-2016-314500
   PubMed Web of Science ®Google Scholar
• Hacker ML, Turchan M, Heusinkveld LE, et al. Deep brain stimulation in early-stage Parkinson disease: five-year outcomes. Neurology. 2020;95(4):e393–e401. doi:10.1212/WNL.0000000000009946
   Web of Science ®Google Scholar
• Hariz MI. Complications of deep brain stimulation surgery. Mov Disord. 2002;17(Suppl 3):S162–166. doi:10.1002/mds.10159
   Google Scholar
• Blomstedt P, Hariz MI. Hardware-related complications of deep brain stimulation: a ten year experience. Acta Neurochir. 2005;147(10):1061–1064. doi:10.1007/s00701-005-0576-5
   PubMed Web of Science ®Google Scholar
• Volkmann J, Albanese A, Kulisevsky J, et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson’s disease. Mov Disord. 2009;24(8):1154–1161. doi:10.1002/mds.22496
   PubMed Web of Science ®Google Scholar
• Hell F, Palleis C, Mehrkens JH, Koeglsperger T. Deep Brain Stimulation Programming 2.0: future Perspectives for Target Identification and Adaptive Closed Loop Stimulation. Front Neurol. 2019;10. doi:10.3389/fneur.2019.00314
   Web of Science ®Google Scholar
• LeMoyne R, Mastroianni T, McCandless C, Currivan C, Whiting D, Tomycz N. Implementation of a Smartphone as a Wearable and Wireless Accelerometer and Gyroscope Platform for Ascertaining Deep Brain Stimulation Treatment Efficacy of Parkinson’s Disease through Machine Learning Classification. Adv Parkinson’s Dis. 2018;7(2):19–30. doi:10.4236/apd.2018.72003
   Google Scholar
• Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disorders. 2008;23(15):2129–2170. doi:10.1002/mds.22340
   PubMed Web of Science ®Google Scholar
• Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology. 2001;56(4):548–551. doi:10.1212/wnl.56.4.548
   PubMed Web of Science ®Google Scholar
• Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, Lang AE. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med. 2001;345(13):956–963. doi:10.1056/NEJMoa000827
   Web of Science ®Google Scholar
• Lyons KE, Wilkinson SB, Tröster AI, Pahwa R. Long-term efficacy of globus pallidus stimulation for the treatment of Parkinson’s disease. Stereotact Funct Neurosurg. 2002;79(3–4):214–220. doi:10.1159/000070834
   Web of Science ®Google Scholar
• Kumar R, Lang AE, Rodriguez-Oroz MC, et al. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson’s disease. Neurology. 2000;55(12 Suppl 6):S34–39.
   PubMed Web of Science ®Google Scholar
• Lu G, Luo L, Liu M, et al. Outcomes and Adverse Effects of Deep Brain Stimulation on the Ventral Intermediate Nucleus in Patients with Essential Tremor. Neural Plast. 2015. doi:10.1155/2020/2486065
   Google Scholar
• Akram H, Dayal V, Mahlknecht P, et al. Connectivity derived thalamic segmentation in deep brain stimulation for tremor. NeuroImage. 2018;18:130–142. doi:10.1016/j.nicl.2018.01.008
   PubMed Web of Science ®Google Scholar
• Wadhwa A, Schaefer S, Gerrard J, Deeb W, Okun MS, Patel A. Deep brain stimulation target selection in co-morbid essential tremor and Parkinson’s disease. Tremor Other Hyperkinetic Movements. 2020;10:17. doi:10.5334/tohm.62
   Web of Science ®Google Scholar
• Cury RG, Fraix V, Castrioto A, et al. Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia. Neurology. 2017;89(13):1416–1423. doi:10.1212/WNL.0000000000004295
   PubMed Web of Science ®Google Scholar
• Thevathasan W, Debu B, Aziz T, et al. Pedunculopontine nucleus deep brain stimulation in Parkinson’s disease: a clinical review. Mov Disorders. 2018;33(1):10–20. doi:10.1002/mds.27098
   PubMed Web of Science ®Google Scholar
• Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson’s disease. Neuroreport. 2005;16(17):1883–1887. doi:10.1097/01.wnr.0000187637.20771.a0
   PubMed Web of Science ®Google Scholar
• Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain. 2007;130(Pt 6):1596–1607. doi:10.1093/brain/awl346
   PubMed Web of Science ®Google Scholar
• Pierantozzi M, Palmieri MG, Galati S, et al. Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson’s disease patients. J Neural Transm. 2008;115(5):731–735. doi:10.1007/s00702-007-0001-8
   Web of Science ®Google Scholar
• Kitagawa M, Murata J, Uesugi H, et al. Two-year follow-up of chronic stimulation of the posterior subthalamic white matter for tremor-dominant Parkinson’s disease. Neurosurgery. 2005;56(2):281–289. doi:10.1227/01.neu.0000148167.49105.a3
   PubMed Web of Science ®Google Scholar